Funding Opportunities

Rockefeller Foundation: Grants Program

Funding: Funding is project specific.

Description: For more than 100 years, The Rockefeller Foundation’s mission has been to promote the well-being of humanity throughout the world. We pursue this mission through dual goals: advancing inclusive economies that expand opportunities for more broadly shared prosperity, and building resilience by helping people, communities and institutions prepare for, withstand, and emerge stronger from acute shocks and chronic stresses. To achieve these goals, The Rockefeller Foundation works at the intersection of four focus areas – advance health, revalue ecosystems, secure livelihoods, and transform cities – to address the root causes of emerging challenges and create systemic change. Together with partners and grantees, we strive to catalyze and scale transformative innovations, create unlikely partnerships that span sectors, and take risks others cannot – or will not.

Eligibility:  Individual and collective health is threatened by an array of challenges, including food insecurity and poor nutrition, infectious and non-communicable diseases, and an aging population. We support innovative strategies that incentivize individuals, communities and governments to address the breadth of variables that contribute to healthy societies, ranging from agriculture to waste and from clean water to resilient health systems. This webform helps determine eligibility.

Deadline:  Inquiries are accepted year-round.


Thrasher Research Fund: E. W. "Al" Thrasher Awards

Funding: Varies but median is $300,000. The grant amount is based on the actual budgetary needs of the project. The duration of the project can be up to three years.

Description: The Thrasher Research Fund has been awarding grants for children's medical research for over 30 years. The purpose of the E.W. "Al" Thrasher Awards is to improve children's health through medical research, with an emphasis on​ projects that have the potential to translate into clinically meaningful results within a few years. The Fund awards grants two times per year, with no fixed number of awards given in each funding cycle or in each year. The Thrasher Research Fund is open to applications that address a variety of significant pediatric problems. Both incidence and severity are considered when determining the significance of the proposed topic. The Fund supports research both within and outside the United States.

Eligibility:  Ideal applications for the E.W. "Al" Thrasher Award address significant health problems that affect children in large numbers and offer the potential for practical solutions to these problems. Such solutions should be innovative and have the potential for rapid and broad applicability with low financial and/or technical barriers to implementation. Hypothesis-driven research is given priority over exploratory, hypothesis-generating research. Principal Investigators must be qualified in terms of education and experience to conduct research. A doctoral-level degree is required. There are no citizenship or residency requirements. The Fund is open to applications from institutions both inside and outside the United States.

Deadline: Concept Papers are accepted on a rolling basis, and are considered by the Fund's Executive Committee approximately once per month.


Wellcome Trust: Strategic Awards in Biomedical Science

Funding: Awards are normally for five years and can provide funds for: equipment, support staff, consumables, networking, biological, clinical or epidemiological research resources.

Description: Strategic Awards provide flexible forms of support to excellent research groups with outstanding track records in their field. In particular, Strategic Awards support research to address the challenges outlined in the Wellcome Trust’s Strategic Plan for 2010-2020. Strategic Awards are funded in partnership with the host institution(s). A written commitment from the institution is a prerequisite to submitting an application; this should explain how the proposal fits with the strategic aims and priorities of the institution. Proposals which involve interdisciplinary research collaborations of basic scientists and/or clinicians (medical and veterinary) and/or non-biologists (e.g. mathematicians, physicists, chemists, engineers, social scientists) are particularly encouraged.

Eligibility:  Applications will be considered from principal applicants who meet our eligibility criteria (below) and are recognised international leaders in their field. Principal applicants must be established researchers who are expected to apply from an eligible organisation, able to sign up to the Wellcome Trust's Grant Conditions and, should normally:
- hold an academic or research post (or equivalent)
- have at least five years' postdoctoral (or equivalent) research experience. Individuals who hold an established lectureship or a well-recognised fellowship (e.g. Royal - Society University Research Fellowship) but who have less than five years' postdoctoral experience are also eligible. Other researchers with less than five years' experience should contact the Grants Information Desk for further advice.
- be in receipt of salary funding for the duration of the grant requested or, if this is not in place, have a position that is underwritten by their employing institution for the duration of the grant.

Deadline: Preliminary applications may be submitted at any time and are assessed on a rolling basis.

 

US National Institutes of Health (NIH): NIAID Clinical Trial Implementation Cooperative Agreement - PAR-13-151

Funding: Application budgets are not limited, but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum period is 5 years. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Description: This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites cooperative agreement applications for implementation of investigator-initiated, high-risk clinical trials and mechanistic studies associated with high-risk clinical trials.  Mechanistic work in clinical trials may be of great value because it promotes the understanding of human diseases and the development of future therapeutic modalities.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on January 13, May 13, and September 11 each year until January 14, 2016.


US National Institutes of Health (NIH): NIAID Clinical Trial Implementation Grant - PAR-13-149

Funding: Application budgets are not limited, but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum period is 5 years. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Description: This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites applications for implementation of investigator-initiated, non-high-risk clinical trials.  The trials must be hypothesis-driven, related to the research mission of the NIAID and considered a high priority by the Institute.  Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID (http://www3.niaid.nih.gov/about/whoWeAre/planningPriorities/). Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation (R01) Grant application.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on January 13, May 13, and September 11 each year until January 14, 2016.


US National Institutes of Health (NIH): NIAID Clinical Trial Planning Grant - PAR-13-150

Funding: $150,000. Application budgets are limited to 150,000 USD direct costs. The scope of the proposed project should determine the project period. The maximum period is one (1) year.

Description: This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites applications that propose the complete planning, design, and preparation of the documentation necessary for implementation of investigator-initiated clinical trials. The trials must be hypothesis-driven, milestone-defined, related to the research mission of the NIAID and considered high priority by the Institute. Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID. (http://www3.niaid.nih.gov/about/whoWeAre/planningPriorities/).

Although clinical research infrastructure is crucial to furthering the Institute’s research, NIAID recognizes that additional models of clinical research may be important to advancing its research mission; therefore, NIAID has established the investigator-initiated clinical trial program for clinical trials that cannot or will not be conducted through existing NIAID-supported clinical trial infrastructure. This program consists of support for the NIAID Clinical Trial Planning (R34) Grant, the NIAID Clinical Trial Implementation (R01) Grant and the NIAID Clinical Trial Implementation (U01) Cooperative Agreement. The NIAID Clinical Trial Implementation (R01) Grant (PAR-13-149) is designed to support non-high-risk clinical trials, while the NIAID Clinical Trial Implementation (U01) Cooperative Agreement (PAR-13-151) is designed to support high-risk clinical trials, as defined by NIAID below and in the associated policy statement (see NOT-AI-10-024). The NIAID Clinical Trial Planning Grant (R34) is available to support planning activities associated with either high- or non-high-risk clinical trials.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on January 13, May 13, and September 11 each year until January 14, 2016.


American Society of Tropical Medicine and Hygiene (ASTMH): Robert E. Shope International Fellowship in Infectious Diseases

Funding: $25,000. Financial support of 25,000 USD for a short-term research experience in the tropics. The funding is to help defray travel costs, living expenses and/or research abroad.

Description: Short-term research experience in the tropics. Provides support for international training opportunities in arbovirology and emerging diseases for those with an MD, DVM, PhD or the equivalent.

Eligibility: Open to full-time post-doctoral fellows (PhD, DVM, MD or the equivalent) with positions at North American institutions who study any tropical infectious disease in arbovirology and/or emerging tropical infectious diseases.

Deadline: Approximate deadline May 14, 2015. Application opens 16-Apr-2015.

US National Institutes of Health (NIH): Research Project Grant - PA-13-302

Funding: Application budgets are not limited, but need to reflect actual needs of the proposed project. Scope of the proposed project should determine the project period. The maximum period is 5 years.

Description: The Research Project Grant (R01) is an award made to an institution/organization to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in areas representing the specific interests and competencies of the investigator(s). The R01 research plan proposed by the applicant institution/organization must be related to the stated program interests of one or more of the NIH Institutes and Centers (ICs) based on descriptions of their programs.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on February 5, June 5, and October 5  each year, until September 8, 2016.


US National Institutes of Health (NIH): Research to Advance Vaccine Safety - PA-12-038

Funding: $275,000. The combined budget for direct costs for the two year project period may not exceed 275,000 USD. No more than 200,000 USD may be requested in any single year. Applicants may request direct costs in 25,000 USD modules, up to the total direct costs limitation for the combined two-year award period.

Description: The purpose of this funding opportunity announcement (FOA) is to support research that will contribute to the overall understanding of vaccine safety. This research opportunity invites studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems, or 5) the application of genomic/molecular technologies to improve knowledge of vaccine safety.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on February 16, June 16, and October 16  each year, until January 8, 2015.


American Society of Tropical Medicine and Hygiene (ASTMH): Centennial Travel Award in Basic Science Tropical Disease Research

Funding: Financial support of 25,000 USD

Description: In an effort to stimulate interest in tropical infectious diseases and build international collaborations, ASTMH seeks applications from physicians and scientists for this international career opportunity focused on benefiting underserved populations in locations in the world where the burden of disease is high. This award also provides physicians and scientists the opportunity for field experience in combination with laboratory studies of parasitic, bacterial or viral infectious diseases in endemic developing countries.

Eligibility:  Full-time postdoctoral fellows (PhD, MD degrees or the equivalent) with positions at U.S. or Canadian institutions who seek travel to laboratories in the tropics to pursue studies in molecular, cellular or immunological aspects of tropical infectious diseases. A minimum of six months to be spent at the overseas site. Applicant must study a tropical infectious disease in one or more of the following disciplines or related areas: immunology, genetics, molecular, biology, biochemistry, cell biology, entomology.

Deadline: Approximate deadline June 25, 2015. Application and deadline details available May-2015.


 IC-IMPACTS Centres of Excellence 

Funding: Up to $400,000 over 2-3 years.

Description:  IC-IMPACTS (India-Canada Centre for Innovative Multidisciplinary Partnerships to Accelerate Community Transformation and Sustainability) is pleased to announce an open call for Collaborative Research Projects between Canada and India.

Applications for Collaborative Research Projects are invited in the following four areas:

  • Safe and Sustainable Infrastructure
    • Condition Assessment and Structural Health Monitoring
    • Repair and Rehabilitation
    • Sustainable and Low Carbon Materials for Repair and Replacement Processes
  • Integrated Water Management
    • Water Quality Monitoring and Sensor Development
    • Water and Wastewater Treatment Technologies
    • New Alternative Power Generation Technologies to support water quality monitoring and wastewater treatment in rural and remote locations
  • Public Health
    • Point of care technologies focusing on detection, monitoring, screening and management of infectious diseases (including water-borne and water-associated disease) with impact in Canadian and Indian communities;
    • Development and evaluation of mobile health technologies that aim to prevent infectious disease and improve health outcomes; and,
    • Application of strategies to prevent infectious diseases and improve health outcomes in the primary health care setting, including the delivery to, and improvement of, maternal and child health.
  • Sociological, Interdisciplinary and Cross-Thematic Research
    • Research into approaches or frameworks for successful application and community adoption of new technologies in remote and rural contexts;
    • Sensor and monitoring technologies that bridge any two or more of IC-IMPACTS core infrastructure, water and public health themes;
    • Research into successful building of community based health awareness that will support technologies developed in the foci of IC-IMPACTS Public Health and Water Management themes.

Eligibility: Any Canadian researcher eligible for funding through the Tri-Agency Granting Councils of Canada

Deadline: In 2014 the deadlines for an LOI were June 24, August 25, and October 20.

US National Institutes of Health (NIH): Research in Latent Tuberculosis Infection (LTBI) in the Setting of HIV Co-Infection - PAR-13-061

Funding: Application budgets are not limited, but need to reflect actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum period is 5 years

Description: The National Institute of Allergy and Infectious Diseases, at the National Institutes of Health invites grant applications which propose research to increase our understanding of the microbiologic adaptive mechanisms, host immunologic factors, and their interactions involved in the development, maintenance, and activation of latent tuberculosis infections (LTBI) with a focus on HIV co-infection.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on July 25, 2014 and July 24, 2015.

Human Frontier Science Program: Postdoctoral Fellowship

Funding:Varies by country

Description: HFSP postdoctoral fellowships encourage early career scientists to broaden their research skills by moving into new areas of study while working in a new country. HFSP fellowships are for three years. Fellows may choose to stay for up to three years in the host country or use the last year of their fellowship to return to their home country or to move to another HFSPO member country. Long-Term Fellowships (LTF) are for applicants with a Ph.D. in a biological discipline, who will broaden their expertise by proposing a project in the life sciences which is significantly different from their previous Ph.D. or postdoctoral work. Cross-Disciplinary Fellowships (CDF) are for applicants with a Ph.D. from outside the life sciences (e.g. in physics, chemistry, mathematics, engineering or computer sciences), who have had limited exposure to biology during their previous training.

Eligibility: Applicants with doctoral degrees in the medical sciences (clinical context) must have an equivalent level of research experience as expected from a research based Ph.D. prior to applying. A candidate who is not a national from one of the supporting countries (Canada) may apply to work only in a research institution in one of the supporting countries. A candidate who is a national of one of the supporting countries can apply to work in a research institution in any country. Candidates who already have a Ph.D. must have obtained their doctoral degree in the 3 years prior to the submission deadline. Please see additonal eligibilities in application guidelines. http://www.hfsp.org/sites/www.hfsp.org/files/webfm/Fellows/2015_Application_Guidelines.pdf

Deadline: The fellowship initiation deadline was 13 August 2014. The fellowship submission deadline was 28 August 2014.


Canadian Institutes of Health Research: Fellowship : HFSP – Postdoctoral Fellowships (2014)

Funding: $46,800. Living, research & travel, and child allowance varies with supporting countries. In United States, fellows is awarded 46,800 USD in their first year. See details in their guidelines.

Description: The Human Frontier Science Program Organization (HFSPO) supports innovative basic research into fundamental biological problems, with emphasis placed on novel approaches that cross disciplinary boundaries. Biological research has become increasingly quantitative through the participation of scientists from biophysics, physics, chemistry, computer science, engineering, mathematics and nanoscience. Such collaborations have led to new approaches for understanding the complex structures and regulatory networks that characterize the evolution and interactions of organisms and biological systems. Within this framework, HFSPO invites applications for its two international postdoctoral programs: Long-Term Fellowships (LTF) are for applicants with a Ph.D. in a biological discipline, who will broaden their expertise by proposing a project in the life sciences which is significantly different from their previous Ph.D. or postdoctoral work. Cross-Disciplinary Fellowships (CDF) are for applicants with a Ph.D. from outside the life sciences (e.g. in physics, chemistry, mathematics, engineering or computer sciences), who have had limited exposure to biology during their previous training.

Eligibility:  A candidate who is not a national from one of the supporting countries may apply to work only in a research institution in one of the supporting countries. A candidate who is a national of one of the supporting countries can apply to work in a research institution in any country. A research doctorate (Ph.D.) or a doctoral-level degree comparable to a Ph.D. with equivalent experience in basic research. Applicants must have at least one lead author research paper.

Deadline: Registration deadline is August 13, 2014, and application deadline is August 28, 2014.

Burroughs Wellcome Fund: Career Awards for Scientific Interface

Deadline: The pre-proposal deadline is September 1, 2014, and full application is due January 8, 2015 (full description under January deadline).


US National Institutes of Health (NIH): NIAID Clinical Trial Implementation Cooperative Agreement - PAR-13-151

Funding: Application budgets are not limited, but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum period is 5 years. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Description: This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites cooperative agreement applications for implementation of investigator-initiated, high-risk clinical trials and mechanistic studies associated with high-risk clinical trials.  Mechanistic work in clinical trials may be of great value because it promotes the understanding of human diseases and the development of future therapeutic modalities.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on January 13, May 13, and September 11 each year until January 14, 2016.


US National Institutes of Health (NIH): NIAID Clinical Trial Implementation Grant - PAR-13-149

Funding: Application budgets are not limited, but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum period is 5 years. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Description: This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites applications for implementation of investigator-initiated, non-high-risk clinical trials.  The trials must be hypothesis-driven, related to the research mission of the NIAID and considered a high priority by the Institute.  Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID (http://www3.niaid.nih.gov/about/whoWeAre/planningPriorities/). Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation (R01) Grant application.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on January 13, May 13, and September 11 each year until January 14, 2016.


US National Institutes of Health (NIH): NIAID Clinical Trial Planning Grant - PAR-13-150

Funding: $150,000. Application budgets are limited to 150,000 USD direct costs. The scope of the proposed project should determine the project period. The maximum period is one (1) year.

Description: This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites applications that propose the complete planning, design, and preparation of the documentation necessary for implementation of investigator-initiated clinical trials. The trials must be hypothesis-driven, milestone-defined, related to the research mission of the NIAID and considered high priority by the Institute. Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID. (http://www3.niaid.nih.gov/about/whoWeAre/planningPriorities/).

Although clinical research infrastructure is crucial to furthering the Institute’s research, NIAID recognizes that additional models of clinical research may be important to advancing its research mission; therefore, NIAID has established the investigator-initiated clinical trial program for clinical trials that cannot or will not be conducted through existing NIAID-supported clinical trial infrastructure. This program consists of support for the NIAID Clinical Trial Planning (R34) Grant, the NIAID Clinical Trial Implementation (R01) Grant and the NIAID Clinical Trial Implementation (U01) Cooperative Agreement. The NIAID Clinical Trial Implementation (R01) Grant (PAR-13-149) is designed to support non-high-risk clinical trials, while the NIAID Clinical Trial Implementation (U01) Cooperative Agreement (PAR-13-151) is designed to support high-risk clinical trials, as defined by NIAID below and in the associated policy statement (see NOT-AI-10-024). The NIAID Clinical Trial Planning Grant (R34) is available to support planning activities associated with either high- or non-high-risk clinical trials.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on January 13, May 13, and September 11 each year until January 14, 2016.


The University of British Columbia: Killam Faculty Research Fellowship

Funding: $15,000.  The maximum award is $15,000 plus a $3000 travel and research expense allowance.

Description and Eligibility:  These awards are open to full-time faculty with tenure regardless of rank, although preference is given to applicants who are no more than 14 years from receipt of their PhD degree. The purpose is to assist research and study during a recognized study leave. These awards are available for any field of study of research other than the ‘Arts’ as presently defined in the Canada Council Act. They are not limited to the ‘Humanities and Social Sciences’ as defined in the Act.

Deadline: September 15, 2014.


Canadian Institutes of Health Research: Fellowship : Banting Postdoctoral Fellowships Program (2014-2015)

Funding: $70,000. The total amount available for this funding opportunity is 3,220,000 CAD enough to fund approximately 23 awards. The total amount available for this award is 70,000 CAD per year for up to two years.

Description: The Banting Postdoctoral Fellowships Program is distinguished from existing postdoctoral fellowships programs by its emphasis on the synergy between an applicant’s individual merit and potential to launch a successful research-intensive career and the host institution’s commitment to the research program and environment with which the applicant is to be affiliated. As such, an applicant’s application to the Banting Postdoctoral Fellowships Program must be completed in full collaboration with the proposed host institution.

Eligibility: Open to both Canadian citizens, permanent residents of Canada and foreign students pursuing a doctoral degree at eligible Canadian universities. Canadian citizens, permanent residents of Canada and foreign citizens are eligible to be nominated for a Vanier CGS. Applicants who currently hold or have held agency-specific awards at the postdoctoral level are eligible to apply to the 2014–15 Banting Postdoctoral Fellowships program only if the term of that funding officially ends on or before September 30, 2015 and prior to the start of the Banting Postdoctoral Fellowship. Early termination of the agency-specific postdoctoral award for the purpose of application to the Banting Postdoctoral Fellowships program is not permitted.

Host institution eligibility: Institutions eligible to host a Banting Fellow include Canadian and foreign universities, affiliated research hospitals, colleges and not-for-profit organizations with a strong research mandate and capacity. Canadian governments (federal, provincial and municipal) and all for-profit organizations are not eligible to participate as host institutions.

Deadline: September 24, 2014

Burroughs Wellcome Fund: Career Awards for Medical Scientists

Funding: $700,000 over a minimum of 5 years

Description: The Career Awards for Medical Scientists (CAMS) program supports physician-scientists to bridge advanced postdoctoral/fellowship training and the early years of faculty service. Proposals must be in the area of basic biomedical, disease-oriented, or translational research. Proposals in health services research or involving large-scale clinical trials are ineligible. Awards are made to degree-granting institutions in the U.S. or Canada on behalf of the awardee.

Eligibility: The ideal candidate will be two years away from becoming an independent investigator, have at least two years or more of postdoctoral research experience, and have a significant publication record. Candidates must be nominated by their dean or department chair at the degree-granting institution where they will conduct the postdoctoral/fellowship training under the award. Applications must be approved by an official responsible for sponsored programs (generally from the grants office, office of research, or office of sponsored programs) at the degree-granting institution. Candidates must be citizens or permanent residents of the U.S. or Canada at the time of application.

Next Deadline: October 1, 2014


The University of British Columbia: Killam Faculty Research Prize

Funding: $5,000

Description and Eligibility: Up to ten prizes in the amount of $5,000 each will be awarded to fulltime faculty members in recognition of outstanding research and scholarly contributions – (five awards) in the arts, social sciences and humanities and (five awards) in the sciences, medicine and applied sciences. All fields of research are included.

Deadline: October 1, 2014.


Canadian Institutes of Health Research: Doctoral Research Award: 2014 -2015  and Doctoral Research Award (Specific Research Areas)

Funding: Recipents receive 30,000 CAD as training stipends and 5000 CAD as research allowance per year.

Description: The CIHR Doctoral Research Awards consist of two programs administered through a single application: The Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Awards (CGS-D) program provides special recognition and support to students who are pursuing a doctoral degree in a health-related field in Canada.Some Canada Graduate Scholarship recipients may be considered for the honour of having their scholarship named a “Canada Graduate Scholarship to Honour Nelson Mandela,” should CIHR deem their application to be aligned with at least one of five themes championed by Mandela: national unity; democracy; freedom and human rights; leadership; children’s participation in society; and children’s health. The Doctoral Foreign Study Award (DFSA) provides special recognition and support to students who are pursuing a doctoral degree in a health-related field abroad.

Eligibility: The program is open to Canadian citizens and permanent residents of Canada at the time of application. Only students engaged in a full-time doctoral program that has a significant research component are eligible to apply. The research component must be a requirement for completion of the program, such as the completion of a thesis, a major research project, a dissertation, a scholarly publication, a presentation and/or an exhibit that is merit/expert reviewed at the institutional level.  Doctoral programs that are based only on course work are not eligible. Joint doctoral programs with a professional degree (e.g. MD/PhD, MBA/PhD, DVM/PhD, etc.) and clinically-oriented doctoral programs (e.g. PhD in Clinical Psychology) are eligible if they have a significant research component as described above. For the purposes of eligibility assessment, the health professional degree portion of the combined degree program will not be counted as graduate study.

Deadline: October 1, 2014 


Canadian Institutes of Health Research: Clinician-Scientist Salary Award 

Funding: $100,000 up to 3 years.

Description: The Clinician Scientist program has two phases. Phase 1 provides stipends for up to six years of training support (an initial three-year award followed by a possible three-year renewal award). Phase 2 provides a contribution to the salary of the recipient for up to six years (initial three-year award followed by a possible three-year renewal award).

This opportunity provides funding for the Phase 2 component of the program and is designed to provide outstanding Clinician Scientists the opportunity to develop and demonstrate their independence in initiating and conducting health research through provision of a contribution to their salary.

Applications to this funding opportunity are restricted to recipients of Clinician Scientist awards. It is the applicant’s responsibility to ensure that the renewal application is submitted at the appropriate time to avoid a gap in the funding period.

Deadline: October 1, 2014.


US National Institutes of Health (NIH): Development of Assays for High-Throughput Screening for Use in Probe and Pre-therapeutic Discovery - PAR-13-364

Description: The purpose of this call is to stimulate the development of assays for high throughput screening (HTS) relevant to processes and diseases specific to the mission of the NIH divisions with the intent of using the assays to screen for small molecule compounds that show desired properties as probes for use in advancing knowledge about the relevant target, identifying new targets, or serving as pre-therapeutic leads.

Funding Details: Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Awards pursuant to this funding opportunity are contingent upon the availability of funds. Funding for up to three years. Maximum funding level unspecified.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the PD/PI is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligbile to apply.

Deadline Details: Applications are due on February 5, June 5, and October 5 until January 8, 2017.


US National Institutes of Health (NIH): Research Project Grant - PA-13-302

Funding: Application budgets are not limited, but need to reflect actual needs of the proposed project. Scope of the proposed project should determine the project period. The maximum period is 5 years.

Description: The Research Project Grant (R01) is an award made to an institution/organization to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in areas representing the specific interests and competencies of the investigator(s). The R01 research plan proposed by the applicant institution/organization must be related to the stated program interests of one or more of the NIH Institutes and Centers (ICs) based on descriptions of their programs.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on February 5, June 5, and October 5  each year, until September 8, 2016.


Canadian Institutes of Health Research: Canada Graduate Scholarships – Michael Smith Foreign Study Supplement (2014-2015)

Funding: $6,000. The total amount available for this funding opportunity is $270,000, enough to fund approximately 45 awards. The maximum amount per award is $6,000 for a defined research study period abroad of a minimum of three months to a maximum of six months. This funding is non-renewable. Supplements of up to $6,000 are available to active CGS Master's, CGS Doctoral or eligible Vanier CGS holders to help offset the costs of undertaking research studies outside Canada for a defined period. Supplements are non-renewable. A defined research study period abroad is for a minimum of three months, to a maximum of six months. The supplement covers costs associated with travel, living and other expenses (such as accommodation, meals, tuition, insurance and other necessary, non-research related costs) during the research period abroad.

Description: The Canada Graduate Scholarships—Michael Smith Foreign Study Supplements (CGS-MSFSS) program supports high-calibre Canadian graduate students in building global linkages and international networks through the pursuit of exceptional research experiences abroad. By accessing international scientific research and training, CGS-MSFSS recipients will contribute to strengthening the potential for collaboration between Canadian universities and affiliated research institutions and universities, or other research institutions outside of Canada.This foreign study supplements program is available to Canadian citizens or permanent residents who hold a Joseph-Armand Bombardier, Alexander Graham Bell or Frederick Banting and Charles Best Canada Graduate Scholarship (CGS) at the master's or doctoral level, or a Vanier CGS Doctoral award.

Deadline: October 14, 2014


US National Institutes of Health (NIH): Research to Advance Vaccine Safety - PA-12-038

Funding: $275,000. The combined budget for direct costs for the two year project period may not exceed 275,000 USD. No more than 200,000 USD may be requested in any single year. Applicants may request direct costs in 25,000 USD modules, up to the total direct costs limitation for the combined two-year award period.

Description: The purpose of this funding opportunity announcement (FOA) is to support research that will contribute to the overall understanding of vaccine safety. This research opportunity invites studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems, or 5) the application of genomic/molecular technologies to improve knowledge of vaccine safety.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on February 16, June 16, and October 16 each year until January 8, 2015.


IC-IMPACTS Centres of Excellence 

Funding: Up to $400,000 over 2-3 years.

Description:  IC-IMPACTS (India-Canada Centre for Innovative Multidisciplinary Partnerships to Accelerate Community Transformation and Sustainability) is pleased to announce an open call for Collaborative Research Projects between Canada and India.

Applications for Collaborative Research Projects are invited in the following four areas:

  • Safe and Sustainable Infrastructure
    • Condition Assessment and Structural Health Monitoring
    • Repair and Rehabilitation
    • Sustainable and Low Carbon Materials for Repair and Replacement Processes
  • Integrated Water Management
    • Water Quality Monitoring and Sensor Development
    • Water and Wastewater Treatment Technologies
    • New Alternative Power Generation Technologies to support water quality monitoring and wastewater treatment in rural and remote locations
  • Public Health
    • Point of care technologies focusing on detection, monitoring, screening and management of infectious diseases (including water-borne and water-associated disease) with impact in Canadian and Indian communities;
    • Development and evaluation of mobile health technologies that aim to prevent infectious disease and improve health outcomes; and,
    • Application of strategies to prevent infectious diseases and improve health outcomes in the primary health care setting, including the delivery to, and improvement of, maternal and child health.
  • Sociological, Interdisciplinary and Cross-Thematic Research
    • Research into approaches or frameworks for successful application and community adoption of new technologies in remote and rural contexts;
    • Sensor and monitoring technologies that bridge any two or more of IC-IMPACTS core infrastructure, water and public health themes;
    • Research into successful building of community based health awareness that will support technologies developed in the foci of IC-IMPACTS Public Health and Water Management themes.

Eligibility: Any Canadian researcher eligible for funding through the Tri-Agency Granting Councils of Canada

Deadline: In 2014 the deadlines for an LOI were June 24, August 25, and October 20.


Wellcome Trust: Translation Fund

Funding: The Wellcome Trust provides funding for the directly incurred costs of the research project.

Description: Translation Awards should bridge the funding gap in the commercialisation of new technologies in the biomedical area. They are designed to be flexible, enabling freedom to innovate and push the boundaries of current knowledge. Our aim is to support exceptional individuals with the brightest minds through larger and bolder awards to accelerate product development. The Fund will consider applications that are either single projects or portfolio programmes. The fund will have strategic highlight areas, however projects covering any aspect of technology development from a range of disciplines - including physical, computational and life sciences - will be considered. Projects must address an unmet need in healthcare or in applied medical research, offer a potential new solution, and have a realistic expectation that the innovation will be developed further by the market. The Trust will normally actively participate in the stewardship of the project and lead on intellectual property management and exploitation.

Eligibility: Eligible institutions are not-for-profit research institutions, including those funded by the Medical Research Council, Cancer Research UK, and the Biotechnology and Biological Sciences Research Council, in the UK, that are able to sign up to Wellcome Trust Grant Conditions. Overseas institutions should confirm their eligibility with Technology Transfer. Commercial companies are eligible to apply either as principal applicants or as collaborators.

Deadline:  October 24, 2014.


Thrasher Research Fund: Early Career Award

Funding: $25,000.  The grant amount is based on the actual budgetary needs of the project, with a maximum of 25,000 USD in direct costs for the entire grant. The duration of the project can be up to two years. Indirect costs of no more than 7% of direct costs will be paid on Early Career Award Program grants. The cost of attending one conference is allowed for the applicant to report findings resulting from Thrasher-supported research. Such travel costs may not exceed 2,000 USD.

Description: The Fund recognizes that young investigators may find it difficult to remain in pediatric research because of a lack of funding. Therefore, the purpose of this program is to encourage the development of medical research in child health by awarding small grants to new researchers, helping them gain a foothold in this important area. In 2014, the Fund will make up to 30 awards total with two funding cycles (15 awards each).
The Fund is open to a variety of research topics important to children's health. Both incidence and severity are considered when determining the significance of a problem being studied. In the Early Career Award Program, the Fund is particularly interested in applicants that show great potential to impact that field of children's health through medical research. Both an applicant's aptitude and inclination toward research are considered. The quality of the mentor and the mentoring relationship are also considered to be important predictors of success.

Eligibility:  1. Physicians who are in a residency/fellowship training program, or who completed that program no more than one year before the date of submission of the Concept Paper.  2. Post-doctoral researchers who received the doctoral level degree no more than three years prior to the date of submission of the Concept Paper. There are no restrictions with regard to citizenship. The Fund is open to applications from institutions both inside and outside the United States.

Deadline: Concept submission deadline is September 12, 2014 and Proposal submission deadline is October 24, 2014.


Canadian Institutes of Health Research: Catalyst Grant : HIV/AIDS Community-Based Research

Funding: $33,000

Description:  The CIHR HIV/AIDS Community-Based Research (CBR) Program is one of five research funding streams of the CIHR HIV/AIDS Research Initiative. The CIHR HIV/AIDS Research Initiative is responsible for the research components of the two major Government of Canada initiatives in HIV/AIDS, namely the Federal Initiative to Address HIV/AIDS in Canada and the Canadian HIV Vaccine Initiative.

The CIHR HIV/AIDS CBR Program supports the partnered work of Community Leaders and Researchers in knowledge development and capacity-building initiatives of relevance to communities engaged in the fight against HIV/AIDS. All opportunities offered through the CBR Program are available in two distinct funding streams: Aboriginal and General.

Community Leaders play an integral role in the research processes to ensure that the research will lead to useful and practical outcomes that will directly benefit the community. For the CIHR HIV/AIDS CBR Program, a Community Leader is defined as an individual who has direct involvement with a community affected by HIV/AIDS, understands the needs of the community and how research can lead to useful practical outcomes for the community, and can facilitate the involvement of the community in the research process. Researchers from academic and other research institutions bring to community groups their research expertise in methodology, scientific rigor and experience in the supervision of future researchers.

The aim of the Catalyst Grant component of the CBR program is to provide seed money, for up to one year, to support HIV/AIDS CBR research activities which represent a first step towards the pursuit of more comprehensive funding opportunities (e.g., operating grants). Please visit the Objectives section for more information.

Deadline: October 27, 2014


Medicines for Malaria Venture: Malaria Box Challenge Grants

Funding: $200,000

Description:  The goal of this call for proposals is to encourage investigators to follow up on Malaria Box open source data, available on ChEMBL, and test the Malaria Box compounds and their derivatives in vivo using animal models of neglected infectious diseases.  This call for applications is to encourage animal model testing of the Malaria Box hit compounds and their derivatives in neglected infectious disease models, such as schistosomiasis, cryptosporidiosis, filariasis, tuberculosis, as well as other infections where there is comorbidity in children with malaria. These Challenge Grants will be prioritized based on scientific merit. They should propose in vivo (animal) studies on neglected infectious diseases that afflict children in malaria endemic countries. We will also consider applications that propose to study malaria in animal models with the Malaria Box compounds or new compound series with novel antimalarial compounds. Please note that for malaria studies, in vivo studies that address transmission blocking and liver stage malaria will be prioritized over in vivo studies that address only the asexual blood stages of malaria.

Eligibility: Open - Investigators and/or co-investigators from malaria-endemic areas are highly encouraged to apply and their applications will be prioritized over applications from non-malaria endemic countries. 

Deadline: October 30, 2014

British Society for Antimicrobial Chemotherapy: Overseas Scholarship

Funding: Successful candidates will be paid a grant of 1,000 GBP per calendar month for a maximum of 6 months. The host institution will receive a consumables grant of 200 GBP per calendar month for the duration of the scholarship. The Society will reimburse the cost of return air fares and travel via the most economical route. Candidates will be asked to seek approval of travel costs in advance

Description: Overseas Scholarships are to enable workers from other countries the opportunity to work in UK Departments for up to six months.

Eligibility: Overseas Scholarships are open to scholars living outside the United Kingdom and are subject to the usual Terms and Conditions for the BSAC Grants Programme. The applicant must provide a statement describing how the visit to the UK, and the training, will benefit the scholar and their institution on their return. Individuals already living, working or researching in the UK are not eligible to apply.

Deadline Details: November 1, 2014.  This is an annual competition.


Burroughs Wellcome Fund: Investigators in the Pathogenesis of Infectious Disease

Funding: $500,000 over 5 years

Description: The Investigators in the Pathogenesis of Infectious Disease program provides opportunities for assistant professors to bring multidisciplinary approaches to the study of human infectious diseases. The goal of the program is to provide opportunities for accomplished investigators still early in their careers to study what happens at the points where human and microbial systems connect. The program supports research that sheds light on the fundamentals that affect the outcomes of this encounter: how colonization, infection, commensalism and other relationships play out at levels ranging from molecular interactions to systemic ones.

This award supports accomplished investigators at the assistant professor level to study pathogenesis, with a focus on the interplay between human and microbial biology, shedding light on how human and microbial systems are affected by their encounters. The awards are intended to give recipients the freedom and flexibility to pursue new avenues of inquiry and higher-risk research projects that hold potential for significantly advancing the biochemical, pharmacological, immunological, and molecular biological understanding of how microbes and the human body interact.
Funding Details: This award provides 500,000 USD over a period of five years.

Candidate: Candidates will generally have an M.D., D.V.M., or Ph.D. degree. Candidates must have an established record of independent research and hold a tenure-track position as an assistant professor or equivalent (at the time of application) at a degree-granting institution. Candidates must be nominated by accredited, degree-granting institutions in the United States or Canada. Applications from non-tenure track investigators in tenure-offering, degree-granting departments or institutions will not be accepted. Candidates must be citizens or permanent residents of the United States or Canada at the time of application.

Institution: A U.S. or Canadian institution— including its medical school, graduate schools, and all affiliated hospitals and research institutes—may nominate up to two candidates. To encourage applications from veterinarians, institutions that nominate a researcher who holds the D.V.M. will be allowed three nominations. Institutions may have a single additional nomination if they nominate a researcher working in pathogenic helminths, mycology, or reproductive science. Institutions may have an additional nomination if they nominate a member of an underrepresented minority group.

Deadline: November 3, 2014


Canadian Institutes of Health Research: Doctoral Research Award: Vanier Canada Graduate Scholarships (2014-2015)

Funding:  The total amount available for this funding opportunity is $8,400,000, enough to fund approximately 56 awards. Trainee stipend: $50,000 per annum.

Description: The Vanier Canada Graduate Scholarship (Vanier CGS) was created to attract and retain world-class doctoral students and to establish Canada as a global centre of excellence in research and higher learning. It is available to both Canadian and international PhD students studying at Canadian universities.

Eligibility: Open to both Canadian citizens, permanent residents of Canada and foreign students pursuing a doctoral degree at eligible Canadian universities. Canadian citizens, permanent residents of Canada and foreign citizens are eligible to be nominated for a Vanier CGS.

Deadline: November 5, 2014


Wellcome Trust: Seeding Drug Discovery

Funding: Project duration will be determined by how advanced the project is. Early-stage drug discovery projects (Screen to Lead) are able to apply for funding for up to two years to facilitate screening of chemical compounds to identify one or more lead series of molecules. Late-stage (Lead to Clinical) projects, where a lead compound has already been identified, are able to apply for funding for up to four years, to support lead optimisation and preclinical development through to clinical trials.

Description: The aim of Seeding Drug Discovery is to develop drug-like, small molecules that will be the springboard for further research and development by the biotechnology and pharmaceutical industry in areas of unmet medical need. A two-point entry system has been introduced to enable projects at an earlier stage in development to be competitive for funding as well as to progress later-stage projects further towards clinical trials.

Eligibility: 

1. Applicants should normally hold a position of responsibility within the eligible organisation and be able to sign up to or comply with the conditions or terms of an award. In addition, postdoctoral research assistants - whether seeking their own salary as part of the grant proposal, funded by the Wellcome Trust on another grant, or funded by another agency - are eligible for coapplicant status if they make a significant contribution to a research proposal and have agreement from their funding agency.

2. Organisations located outside of the UK should contact Technology Transfer staff regarding their proposed project.Proposals will be taken forward by invitation only.Uninvited applications will not be considered.UK organisations may contract or collaborate with overseas organisations.

Deadline: Applications are due on June 8 and November 5, 2014.


Bill and Melinda Gates Foundation: Grand Challenges Explorations

Funding: $100,000

Description:  Unorthodox thinking is essential to overcoming the most persistent challenges in global health. Vaccines were first developed over 200 years ago because revolutionary thinkers took an entirely new approach to preventing disease.  Grand Challenges Explorations fosters innovation in global health research. The Bill & Melinda Gates Foundation has committed $100 million to encourage scientists worldwide to expand the pipeline of ideas to fight our greatest health challenges.

Round 14 topics:

  • Enabling Universal Acceptance of Mobile Money Payments: We seek new solutions that promote the use of mobile phone-based payments by smaller merchants, service providers, and others serving the poor.
  • Reducing Childhood Deaths from Pneumonia: We seek new ways to reduce pneumonia fatalities through timely, effective treatment of children.
  • Reducing Malaria Transmission by Outdoor Mosquitoes: We seek to reduce malaria parasite transmission that occurs by mosquito bites outdoors, which is not addressed by the insecticide treated nets and indoor sprays that are effective in preventing transmission within houses at night.
  • Supporting New Mosquito-control Approaches: We seek new ways to capture and test mosquitos and grow them in the laboratory to support new approaches for controlling mosquito-borne diseases.
  • Measuring Brain Development and Gestational Age: We seek better ways to measure cognitive development and gestational age, which are critical for designing and assessing the effectiveness of strategies targeting children’s healthy growth and development. This topic is being undertaken in partnership with Grand Challenges Canada's Saving Brains initiative.
  • Integrating Community-based Interventions: We seek new ideas for integrating existing mass drug administration platforms for neglected tropic diseases with other community-based health interventions or services, with the goal of increasing the efficiency and impact of both types of programs.

Eligibility: Open

Deadline: November 12, 2014


Fulbright Canada: Traditional Fulbright Scholar Awards

Funding: The award is a fixed sum of 25,000 USD for a full academic year (nine months) or 12,500 USD for one semester. Basic health insurance is also provided.

Description: Traditional Fulbright Scholar awards for Canadian scholars are open to scholars in all fields (excluding medical training) and are designed to enable emerging and established scholars, post-doctoral researchers and experienced professionals to conduct research, teach, or undertake a combination of both activities for one semester or a full academic year at a university or research centre of their choice in the United States.

Eligibility:  Must be Canadian citizens (landed immigrant or permanent resident status is not acceptable) at the time of the application.  Not had significant recent experience in the United States. Cannot be dual citizens of both Canada and the United States, they cannot presently reside in the United States. Applicants must have received a Ph.D. or equivalent professional/terminal degree by December 31, 2012 or have equivalent professional experience.

Deadline: November 15, 2014. Application opens May 15, 2014.


Fulbright Canada: Fulbright Visiting Research Chairs

Funding: $25,000. Provisions for Fulbright Visiting Chair awards are particular to each institution, though normally carry a value of 25,000 USD for one semester. Basic health insurance is also provided, along with visa services and on campus support.

Description: Canada-U.S. Fulbright Visiting Research Chairs enable promising and prominent Canadian scholars, as well as experienced professionals to conduct research, develop collaborations, guest lecture and/or teach at select American universities and research centres, normally for one semester, though this may be extended to a full academic year. In addition, successful candidates will have the opportunity to deliver public lectures, give seminar presentations, participate in conferences and otherwise contribute to ongoing research activities at the host institution.

Eligibility:  Must be Canadian citizens (landed immigrant or permanent resident status is not acceptable) at the time of the application. Not had significant recent experience in the United States. Cannot be dual citizens of both Canada and the United States, they cannot presently reside in the United States. Applicants must have received a Ph.D. or equivalent professional/terminal degree or have equivalent professional experience.

Deadline: November 15, 2014. Application opens  May 15, 2014.


US National Institutes of Health (NIH): Dissemination and Implementation Research in Health - PA-13-054

Funding: $275,000.  Direct costs are limited to 275,000 USD over an R21 two-year period, with no more than 200,000 USD in direct costs allowed in any single year. The total project period for an application submitted in response to this funding opportunity may not exceed two years.

Description: This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, evaluate and refine effective and efficient methods, systems, infrastructures, and strategies to disseminate and implement research-tested health behavior change interventions, evidence-based prevention, early detection, diagnostic, treatment and management, and quality of life improvement services, and data monitoring and surveillance reporting tools into public health and clinical practice settings that focus on patient outcomes.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline:  Applications are due March 16, July 16, and November 16 each year until January 8, 2016.


Canadian Institutes of Health Research: Knowledge Synthesis Grant : Fall 2014 Competition

Funding: $50,000. The total amount available for this funding opportunity is $1.5 million, enough to fund approximately fifteen grants.The maximum amount for a knowledge synthesis is $100,000 for up to one year. The maximum amount for a scoping review is $50,000 for up to one year.

Description: CIHR's mandate is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system. The purpose of this funding opportunity is to support teams of researchers and knowledge users to produce knowledge syntheses and scoping reviews that will contribute to the use of synthesized evidence in decision-making and practice. Knowledge syntheses are the cornerstone of knowledge translation. They transform vast libraries of scientific literature into knowledge that is reliable, relevant and readable for knowledge users. Syntheses are comprehensive and apply scientific methods to literature analysis which minimizes the risk of bias and error that may accompany single studies, so decisions are less likely to be based on insufficient or premature evidence. Syntheses are also a means to integrate the established literature with other forms of knowledge or map the state of current knowledge on a topic, revealing to knowledge users where there is or is not strong evidence to inform their decisions, and guiding researchers to new avenues for primary research.

Eligibility: For your application to be eligible: It must include at least two Project Leaders: an independent researcher and a knowledge user. Although both individuals are considered Project Leaders, these individuals will need to identify if they are an independent researcher or a knowledge user in ResearchNet.  The Project Leader(s), who are independent researchers, must be registered at an eligible institution (see Institutional Eligibility Requirements for eligibility process and associated timelines). There is no maximum number of Project Leaders & Project Experts (researchers or knowledge users) who can be included on a Knowledge Synthesis grant. Applications to undertake Cochrane reviews are eligible only if the requested funds will not overlap with funding from the Canadian Cochrane Centre (CCC). - Applicants must have at least one lead author research paper.

Deadline: November 17, 2014.


Canadian Institutes of Health Research: Team Grant : Pathways Implementation Research Team – Component 2

Funding: The maximum amount per grant is $225,000/year for up to 3 years. A minimum of $75,000/year for up to 3 years must be supported by applicant partners.  Up to 10 Development grants of $5,000 will be offered, if requested, to successful applications at the Letter of Intent stage.

Description:  Pathways to Health Equity for Aboriginal Peoples (Pathways) is a CIHR Signature Initiative with an overall goal to develop a better understanding of how to design, implement and scale up population health interventions that will improve Aboriginal health in four exemplars – Suicide prevention, Diabetes/Obesity, Tuberculosis, and Oral Health. Although Pathways prioritizes four health challenges, knowledge gained from researching these exemplars will be useful for reducing inequities in other related areas that affect Aboriginal peoples, including mental health (especially substance abuse, depression, and stigmatization), communicable diseases (such as HIV and sexually transmitted diseases), chronic diseases (including cardiovascular disease, osteoporosis, and cancer) and health systems research (such as the delivery of community-based primary health care in remote areas and the use of e-health approaches). While direct action on the social determinants of health is not a primary focus of Pathways, this initiative will involve interventions that take the social determinants of health and the broader structural and policy context into consideration.

Eligibility: Complex - please see grant page.

Deadline: Letter of Intent - November 26, 2014, Application: September 15, 2015.

Canadian Institutes of Health Research: New Investigator Salary Award

Funding: $60,000 up to 5 years

Description: A new investigator is defined as a researcher who has held a full time research appointment (e.g. faculty appointment providing eligibility to apply for grants and/or supervise trainees), for a period of 0 to 60 months.  The objective of the New Investigator Salary Award program is to provide outstanding new investigators with the opportunity to develop and demonstrate their independence in initiating and conducting health research through provision of a contribution to their salary.  

Eligibility:  The Nominated Principal Applicant must be an independent researcher. The Nominated Principal Applicant must have an academic or research appointment at an eligible institution (See Institutional Eligibility Requirements for eligibility process and associated timelines.

At the time of application, applicants must meet all the following eligibility criteria:

  • have obtained a full time professional degree (MD, DVM, etc...) or PhD degree within the last 10 years. Individuals that fall outside of the 10-year eligibility period due to career interruptions or delays for the purpose of childrearing, illness, or health-related family responsibilities; or, for health professionals only, who have engaged in post-degree non-research related clinical training (residency, etc.), must submit a justification to explain why they feel they should be considered eligible.
  • the Nominated Principal Applicant must have a full-time academic or research appointment, or a formal commitment to a full-time academic or research appointment at an eligible institution.
  • hold a full-time appointment as an independent researcher (e.g., faculty appointment providing eligibility to apply for grants and/or supervise trainees) for a period of 0 to 60 months. If the applicant does not yet meet this condition, the applicant needs to have a formal commitment from the Institution to a full-time appointment as an independent researcher, with an effective start date as of the commencement of the award. This commitment must be demonstrated in the Dean of Faculty/Research Director Letter.

Deadline: December 1, 2104


MITACS -  Globalink Research Award – Inria

Funding: $5,000 travel / expenses and $1,000 month from host.

Description: The Mitacs Globalink Research Award - Inria is an exciting new competitive initiative that provides the opportunity for faculty members and graduate students at Canadian universities to build an international research network and undertake research abroad at Inria Research Centres.  The Globalink Research Award - Inria offers graduate students at Mitacs full and associate partner universities in Canada the opportunity to participate in 12– to 24–week research projects supervised by a recognized research member at Inria.

Inria is dedicated to fundamental and applied research in information and communication science and technology and is organized around five main fields of research:  

  • Applied mathematics, computation and simulation
  • Algorithmic, programming, software and architecture
  • Networks, systems and services, distributed computing
  • Perception, cognition, interaction
  • Digital Health, Biology and Earth

The call for applications will open on September 30, 2014 and will close on December 1, 2014 at 5 p.m. PST. This is a competitive call and a limited number of awards are available. Successful applicants can begin their Research Award as early as March 2nd 2015 and as late as December 31st  2015.

Deadline: December 1, 2014; 5pm


Canadian Institutes of Health Research: Masters Award

Funding: $17,000 per year.

Description:  The Canada Graduate Scholarships Master's Awards are intended to provide special recognition and support to students who are pursuing a Master's degree in a health related field at a Canadian institution. These candidates are expected to have an exceptionally high potential for future research achievement and productivity.

Some Canada Graduate Scholarship recipients may be considered for the honour of having their scholarship named a “Canada Graduate Scholarship to Honour Nelson Mandela”, should CIHR deem their application to be aligned with at least one of five themes championed by Mandela: national unity; democracy; freedom and human rights; leadership; children’s participation in society; and children’s health.

Deadline: December 1, 2014.

NEW Department of Foreign Affairs, Trade and Development:  Partnerships for Maternal, Newborn, and Child Health

Funding: A total value of up to $370 million over five years (2015–2020) and has two streams: Stream 1 will fund initiatives valued at between $1 million and $19 million, and has a total budget of as much as $100 million. Stream 2 will fund initiatives valued at more than $20 million, and has a total budget of as much as $270 million.

Description: This call is designed to fund initiatives that contribute to progress on the issue of maternal, newborn and child health (MNCH) and are in line with one or more of the four following paths: Strengthening health systems to improve appropriate health service access and delivery at the local level by training more health workers and facilitating access for mothers and children to necessary health care facilities and interventions. For example, activities that improve access to antenatal care, skilled attendants present at childbirth, newborn survival, postpartum care, sexual and reproductive health care, and health education.

Reducing the burden of diseases that are killing mothers and children by increasing the coverage of interventions proven to address the main causes of death in mothers, newborns and children. For example, activities that contribute to the prevention, management and treatment of pneumonia, diarrhea, malaria and HIV/AIDS. Improving nutrition by increasing access to healthy and nutritious food and nutritional supplements aimed at reducing mortality, especially among newborns. For example, activities that support nutrition, nutrition education and breastfeeding; improve consumption practices and community-level food security; and increase the provision of micronutrients. Ensuring accountability for results to improve transparency and the quality of statistics and information made available to the public. For example, by supporting the strengthening of national civil registration and vital statistics systems, and disseminating timely and relevant data for planning and decision making.

Eligibility The call for proposals is open to Canadian organizations and private sector companies legally incorporated in Canada with at least two years of experience in managing and delivering international development initiatives for Stream 1 and five years of experience in managing and delivering international development initiatives related to improving the health of mothers, newborns and children in developing countries for Stream 2.

Deadline: January 15, 2015


NEW US National Institutes of Health: Innovative Technologies for Differential Diagnosis of Acture Febrile Illnesses (R21/R33)

Funding:  $200,000 to $375,000 per year depending on grant.

Description: This Funding Opportunity Announcement (FOA) will provide support for research projects to establish proof-of-concept for novel, rapid and innovative medical diagnostic technologies and/or early-stage product development activities. The primary goal of such a diagnostic is to initiate appropriate therapeutic treatment during the initial visit for patients presenting acute fever in any point-of-care setting.

Research objectives may include the initial development of a novel technology or adaptation of an emerging technology to detect pathogens associated with acute febrile illnesses. Detection of host factors that would provide a differential diagnosis of bacterial infection that may provide clinically actionable information may also be included. A principal objective of this FOA is the development of innovative and novel diagnostic technologies. The following research areas are of particular interest:

  • Technologies that analyze clinical samples more accurately and rapidly than current diagnostic platforms and have utility within, or provide improvements upon, current clinical care and treatment.
  • Technologies capable of measuring in vivo analytes.
  • Integrated sample-to-answer sequencing-based platforms.
  • Diagnostic platforms that simultaneously detect multiple biomarkers.

For this FOA, the proposed diagnostic must be incubation-independent (i.e. designed to detect pathogens without requiring culture-bottle and/or streak plate incubations). Assays that can distinguish simultaneously between classes of pathogens (e.g. bacterial versus viral) are encouraged. At the end of the project period, a successful project will have demonstrated proof of principle with the capability of the developed technology to detect targeted pathogens in relevant live animal infection models (for in vivo detection technologies) or human clinical samples. For the purpose of this FOA, the following features are of greatest importance for a proposed diagnostic:

  • Rapid: a target diagnostic test time of <1 hour to final result, including time required for clinical sample processing (if appropriate).
  • Culture independent: the diagnostic should focus on direct detection of pathogens or other biomarkers from human clinical samples.
  • Sensitive: the sensitivity should be equivalent to or exceed that of FDA-cleared diagnostics for proposed agent(s) from the same sample type.
  • Specific: the specificity should be equivalent to or exceed that of FDA-cleared diagnostics for proposed agent(s) from the same sample type.
  • Easy to use: for example, an integrated, closed sample-to-answer system with automated data analyses and/or result presentation and with minimal operator training and expertise required.
  • Cost-effective: projected production and operating costs should be as inexpensive as possible.

Eligibility: Foreign Entities and Institutes are eligible to apply.

Deadline: LOI January 2, 2015, Application February 5, 2015


Burroughs Wellcome Fund: Career Awards for Scientific Interface

Funding: $500,000

Description: BWF's Career Awards at the Scientific Interface (CASI) provide $500,000 over five years to bridge advanced postdoctoral training and the first three years of faculty service. These awards are intended to foster the early career development of researchers who have transitioned or are transitioning from undergraduate and/or graduate work in the physical/mathematical/computational sciences or engineering into postdoctoral work in the biological sciences, and who are dedicated to pursuing a career in academic research. These awards are open to U.S. and Canadian citizens or permanent residents as well as to U.S. temporary residents.

Scientific advances such as genomics, quantitative structural biology, imaging techniques, and modeling of complex systems have created opportunities for exciting research careers at the interface between the physical/computational sciences and the biological sciences. Tackling key problems in biology will require scientists trained in areas such as chemistry, physics, applied mathematics, computer science, and engineering.
Recognizing the vital role such cross-trained scientists will play in furthering biomedical science, the Burroughs Wellcome Fund has developed the Career Awards at the Scientific Interface. These grants are intended to foster the early career development of researchers who have transitioned or are transitioning from undergraduate and/or graduate work in the physical/mathematical/computational sciences or engineering into postdoctoral work in the biological sciences, and who are dedicated to pursuing a career in academic research.

Eligibility: Candidates are expected to draw from their training in a scientific field other than biology to propose innovative approaches to answer important questions in the biological sciences. Candidates must hold a Ph.D. degree in one of the fields of mathematics, physics, chemistry, computer science, statistics, or engineering.  - Candidates must have completed at least 12 months but not more than 48 months of postdoctoral research by the date of the full invited application deadline. Candidates cannot hold nor have accepted, either in writing or verbally, a faculty appointment as a tenure-track assistant professor at the time of application - both preproposal and full application. Citizens and non-citizen permanent residents of the U.S. and Canada are eligible. Temporary residents of the U.S. are eligible.

Deadline: The pre-proposal deadline is September 1, 2014 and full application is due January 8, 2015.


US National Institutes of Health (NIH): NIAID Clinical Trial Implementation Cooperative Agreement - PAR-13-151

Funding: Application budgets are not limited, but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum period is 5 years. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Description: This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites cooperative agreement applications for implementation of investigator-initiated, high-risk clinical trials and mechanistic studies associated with high-risk clinical trials.  Mechanistic work in clinical trials may be of great value because it promotes the understanding of human diseases and the development of future therapeutic modalities.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on January 13, May 13, and September 11 each year until January 14, 2016.


US National Institutes of Health (NIH): NIAID Clinical Trial Implementation Grant - PAR-13-149

Funding: Application budgets are not limited, but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum period is 5 years. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Description: This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites applications for implementation of investigator-initiated, non-high-risk clinical trials.  The trials must be hypothesis-driven, related to the research mission of the NIAID and considered a high priority by the Institute.  Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID (http://www3.niaid.nih.gov/about/whoWeAre/planningPriorities/). Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation (R01) Grant application.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on January 13, May 13, and September 11 each year until January 14, 2016.


US National Institutes of Health (NIH): NIAID Clinical Trial Planning Grant - PAR-13-150

Funding: $150,000. Application budgets are limited to 150,000 USD direct costs. The scope of the proposed project should determine the project period. The maximum period is one (1) year.

Description: This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites applications that propose the complete planning, design, and preparation of the documentation necessary for implementation of investigator-initiated clinical trials. The trials must be hypothesis-driven, milestone-defined, related to the research mission of the NIAID and considered high priority by the Institute. Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID. (http://www3.niaid.nih.gov/about/whoWeAre/planningPriorities/).

Although clinical research infrastructure is crucial to furthering the Institute’s research, NIAID recognizes that additional models of clinical research may be important to advancing its research mission; therefore, NIAID has established the investigator-initiated clinical trial program for clinical trials that cannot or will not be conducted through existing NIAID-supported clinical trial infrastructure. This program consists of support for the NIAID Clinical Trial Planning (R34) Grant, the NIAID Clinical Trial Implementation (R01) Grant and the NIAID Clinical Trial Implementation (U01) Cooperative Agreement. The NIAID Clinical Trial Implementation (R01) Grant (PAR-13-149) is designed to support non-high-risk clinical trials, while the NIAID Clinical Trial Implementation (U01) Cooperative Agreement (PAR-13-151) is designed to support high-risk clinical trials, as defined by NIAID below and in the associated policy statement (see NOT-AI-10-024). The NIAID Clinical Trial Planning Grant (R34) is available to support planning activities associated with either high- or non-high-risk clinical trials.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on January 13, May 13, and September 11 each year until January 14, 2016.


 

NEW Bill & Melinda Gates Foundation: Grand Challenges in Global Health

Funding:  $100,000 with prospect of phase II grants of up to $1,000,000.

Description:  Several new themes for this round.  Putting Women and Girls at the Center of Development: focuses on how to effectively reach and empower the most vulnerable women and girls to improve health and development – including economic – outcomes as well as gender equality.  Creating and Measuring Integrated Solutions for Health Birth, Growth and Development: focuses on new measurement tools and new combinations of approaches to ensure all children thrive – that they not only survive, but also have the chance to live healthy productive lives. New Interventions for Global Health: focuses on innovative concepts for vaccines, therapeutics, and diagnostics with the potential to be translated into safe, effective, affordable, and widely utilized interventions to protect against the acquisition, progression, or transmission of infectious diseases, or to provide a cure for infectious diseases, in resource‐limited settings.

Eligibility:  Grants will go to investigators in low- and middle-income countries, but we encourage partnerships with investigators in other countries, especially where the opportunity exists to build on existing collaborations.

Deadline: Letter of Interest due January 13, 2015, full application June 2, 2015.

NEW US National Institutes of Health (NIH): Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01)

Funding:  Phase 1 studies are eligible for grants of up to $250,000 per year for up to 3 years.  Phase 2 and 3 studies are eligible for grants of up to $500,000 per year for up to 4 years.

Description:  The goal of FDA's OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the product being developed will be superior to the existing therapy.  FDA provides grants for clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products. Applicants must include in the application's Background and Significance section documentation to support the assertion that the orphan disease or condition to be studied is a “rare disease or condition” and an explanation of how the proposed study will either help support product approval or provide essential data needed for product development.

Eligibility:  Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Deadline: Applications are due on February 4, 2015; February 3, 2016; February 1, 2017; February 7, 2018 by 11:59 PM Eastern Time


US National Institutes of Health (NIH): Development of Assays for High-Throughput Screening for Use in Probe and Pre-therapeutic Discovery - PAR-13-364

Description: The purpose of this call is to stimulate the development of assays for high throughput screening (HTS) relevant to processes and diseases specific to the mission of the NIH divisions with the intent of using the assays to screen for small molecule compounds that show desired properties as probes for use in advancing knowledge about the relevant target, identifying new targets, or serving as pre-therapeutic leads.

Funding Details: Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Awards pursuant to this funding opportunity are contingent upon the availability of funds. Funding for up to three years. Maximum funding level unspecified.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the PD/PI is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligbile to apply.

Deadline Details: Applications are due on February 5, June 5, and October 5 until January 8, 2017.


US National Institutes of Health (NIH): Development of Assays for High-Throughput Screening for Use in Probe and Pre-therapeutic Discovery - PAR-13-364

Description: The purpose of this call is to stimulate the development of assays for high throughput screening (HTS) relevant to processes and diseases specific to the mission of the NIH divisions with the intent of using the assays to screen for small molecule compounds that show desired properties as probes for use in advancing knowledge about the relevant target, identifying new targets, or serving as pre-therapeutic leads.

Funding Details: Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Awards pursuant to this funding opportunity are contingent upon the availability of funds. Funding for up to three years. Maximum funding level unspecified.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the PD/PI is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligbile to apply.

Deadline Details: Applications are due on  February 5, June 5, and October 5 until January 8, 2017.


US National Institutes of Health (NIH): Research Project Grant - PA-13-302

Funding: Application budgets are not limited, but need to reflect actual needs of the proposed project. Scope of the proposed project should determine the project period. The maximum period is 5 years.

Description: The Research Project Grant (R01) is an award made to an institution/organization to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in areas representing the specific interests and competencies of the investigator(s). The R01 research plan proposed by the applicant institution/organization must be related to the stated program interests of one or more of the NIH Institutes and Centers (ICs) based on descriptions of their programs.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on February 5, June 5, and October 5  each year, until September 8, 2016.


US National Institutes of Health (NIH): Research to Advance Vaccine Safety - PA-12-038

Funding: $275,000. The combined budget for direct costs for the two year project period may not exceed 275,000 USD. No more than 200,000 USD may be requested in any single year. Applicants may request direct costs in 25,000 USD modules, up to the total direct costs limitation for the combined two-year award period.

Description: The purpose of this funding opportunity announcement (FOA) is to support research that will contribute to the overall understanding of vaccine safety. This research opportunity invites studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems, or 5) the application of genomic/molecular technologies to improve knowledge of vaccine safety.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Foreign institutions are eligible to apply.

Deadline: Applications are due on February 16, June 16, and October 16 each year until January 8, 2015.

American Society of Tropical Medicine and Hygiene (ASTMH): Benjamin H. Kean Travel Fellowship in Tropical Medicine

Funding:  Funding will cover Round-trip coach airfare and up to 1000 USD reimbursement of living expenses.

Description: Provides travel expenses for medical students who arrange clinical tropical medicine or tropical medicine research electives in areas afflicted by tropical diseases.

Eligibility:  Applicants must meet the following criteria: Open to full-time medical students in North American accredited schools of medicine. Research or clinical training in tropical medicine or global health with at least one month at site endemic for tropical diseases.

Deadline: Approximate deadline March 1, 2015. Application and deadline details available Feb-2015.

Burroughs Wellcome Fund: Innovation in Regulatory Science Award

Funding: $500,000

Description: The Burroughs Wellcome Fund is inviting pre-proposals for its 2015 Innovation in Regulatory Science Awards. Through the program, grants of up to $500,000 over five years will be awarded to academic investigators working to develop new methodologies or innovative approaches in regulatory science that ultimately inform the regulatory decisions made by the Food and Drug Administration and other agencies.

Eligibility: To be eligible, applicants must hold an M.D., Ph.D., D.V.M., D.D.S., or M.D.-Ph.D. degree; be based at a nonprofit institution in the United States or Canada; must hold a faculty position at an accredited, degree-granting institution in the United States or Canada; and must be an investigator at the adjunct, assistant, associate, or full professor level. In addition, applicants must be citizens or permanent residents of the U.S. or Canada at the time of application.

Deadline: Pre-proposal November 18, 2014 with invited final submission April 1, 2015.